Learn more about our databases and growing test menu.
MGMT promoter methylation status is "an essential part of molecular diagnostics for all high-grade gliomas" as stated by NCCN guidelines. The methylation status is a predictor for TMZ treatment in CNS tumors, as well as a prognostic marker.
The JAX OncoMethyl Array™ utilizes a machine learning algorithm intended to provide supplemental information for the classification of central nervous system (CNS) tumors based on genomic methylation profiling data.
Reports on 517 cancer related genes for assessment of all DNA and RNA variant types such as SNVs, CNVs, indels, and fusions, in addition to MSI and TMB.
JAX-Clinical Knowledgebase (CKB) is a powerful tool for interpreting complex genomic profiles, and represents a valuable resource for clinicians and translational and clinical researchers around the world.
Browse profiles of our Clinical Genomics leadership team.
Download requisition forms to get your tests started today.